Sign Out
Thenox is a low-molecular weight heparin (LMWH). It is indicated for: Prophylaxis of post operative deep vein thrombosis (DVT) and/or pulmonary embolism (PE): Prophylaxis of DVT may lead to pulmonary embolism in patients undergoing general surgery including abdominal, hip or knee replacement, cancer surgery, who are at risk for thromboembolic complications.
Prophylaxis of deep vein thrombosis (DVT) in medical patients with an acute illness: Medically patients who are at risk for thromboembolic complications because of severely restricted mobility during acute illness such as acute heart failure, or NYHA Class III or IV, acute respiratory failure, severe lung diseases, acute/severe infections or acute rheumatic diseases.
Treatment of acute deep vein thrombosis (DVT) and/or pulmonary embolism (PE): Inpatient treatment of acute DVT with or without pulmonary embolism, when administered in conjunction with warfarin; for outpatient treatment of acute DVT without pulmonary embolism, when administered in conjunction with warfarin.
Prevention of thrombus formation (Clotting) in the extracorporeal circulation during hemodialysis.
Treatment of acute ST-segment elevation myocardial infarction (STEMI), in patients receiving thrombolysis and being managed medically or with percutaneous coronary intervention (PCI).
Prophylaxis and treatment of ischemic complications of unstable angina and non-ST elevation myocardial infarction (NSTEMI), when coadministered with aspirin and/or other therapy.
